Annual EBITDA
-$75.74 M
+$23.76 M+23.88%
December 31, 2023
Summary
- As of February 8, 2025, PAVM annual EBITDA is -$75.74 million, with the most recent change of +$23.76 million (+23.88%) on December 31, 2023.
- During the last 3 years, PAVM annual EBITDA has fallen by -$39.93 million (-111.50%).
- PAVM annual EBITDA is now -4163.31% below its all-time high of -$1.78 million, reached on December 31, 2015.
Performance
PAVM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$60.96 M
+$75.56 M+517.60%
September 30, 2024
Summary
- As of February 8, 2025, PAVM quarterly EBITDA is $60.96 million, with the most recent change of +$75.56 million (+517.60%) on September 30, 2024.
- Over the past year, PAVM quarterly EBITDA has increased by +$81.82 million (+392.27%).
- PAVM quarterly EBITDA is now at all-time high.
Performance
PAVM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$11.79 M
+$81.82 M+116.83%
September 30, 2024
Summary
- As of February 8, 2025, PAVM TTM EBITDA is $11.79 million, with the most recent change of +$81.82 million (+116.83%) on September 30, 2024.
- Over the past year, PAVM TTM EBITDA has increased by +$94.48 million (+114.26%).
- PAVM TTM EBITDA is now at all-time high.
Performance
PAVM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PAVM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.9% | +392.3% | +114.3% |
| 3 y3 years | -111.5% | +319.6% | +114.7% |
| 5 y5 years | -380.3% | +319.6% | +114.7% |
PAVM EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -35.5% | +23.9% | at high | +312.4% | at high | +111.6% |
| 5 y | 5-year | -339.8% | +23.9% | at high | +312.4% | at high | +111.6% |
| alltime | all time | -4163.3% | +23.9% | at high | +312.4% | at high | +111.6% |
PAVmed EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $60.96 M(-517.6%) | $11.79 M(-116.8%) |
| Jun 2024 | - | -$14.60 M(-18.5%) | -$70.03 M(-3.2%) |
| Mar 2024 | - | -$17.91 M(+7.5%) | -$72.35 M(-4.5%) |
| Dec 2023 | -$75.74 M(-23.9%) | -$16.66 M(-20.1%) | -$75.74 M(-8.4%) |
| Sep 2023 | - | -$20.86 M(+23.3%) | -$82.69 M(-8.7%) |
| Jun 2023 | - | -$16.92 M(-20.6%) | -$90.54 M(-10.7%) |
| Mar 2023 | - | -$21.30 M(-9.8%) | -$101.39 M(+1.9%) |
| Dec 2022 | -$99.50 M(+78.0%) | -$23.61 M(-17.7%) | -$99.50 M(+4.3%) |
| Sep 2022 | - | -$28.71 M(+3.4%) | -$95.40 M(+18.8%) |
| Jun 2022 | - | -$27.76 M(+43.0%) | -$80.33 M(+23.2%) |
| Mar 2022 | - | -$19.42 M(-0.5%) | -$65.22 M(+21.1%) |
| Dec 2021 | -$55.90 M(+56.1%) | -$19.51 M(+43.1%) | -$53.87 M(+23.5%) |
| Sep 2021 | - | -$13.64 M(+7.8%) | -$43.61 M(+21.7%) |
| Jun 2021 | - | -$12.65 M(+56.9%) | -$35.84 M(+23.5%) |
| Mar 2021 | - | -$8.06 M(-12.8%) | -$29.02 M(-19.0%) |
| Dec 2020 | -$35.81 M(+108.0%) | -$9.25 M(+57.7%) | -$35.81 M(+8.3%) |
| Sep 2020 | - | -$5.87 M(+0.5%) | -$33.08 M(+8.5%) |
| Jun 2020 | - | -$5.84 M(-60.7%) | -$30.48 M(+7.4%) |
| Mar 2020 | - | -$14.86 M(+128.0%) | -$28.38 M(+64.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$17.22 M(+9.2%) | -$6.52 M(+99.4%) | -$17.22 M(+1.7%) |
| Sep 2019 | - | -$3.27 M(-12.5%) | -$16.94 M(+4.3%) |
| Jun 2019 | - | -$3.73 M(+0.9%) | -$16.24 M(-5.3%) |
| Mar 2019 | - | -$3.70 M(-40.6%) | -$17.15 M(+8.7%) |
| Dec 2018 | -$15.77 M(+79.5%) | -$6.23 M(+142.8%) | -$15.77 M(+90.0%) |
| Sep 2018 | - | -$2.57 M(-44.7%) | -$8.30 M(-20.9%) |
| Jun 2018 | - | -$4.64 M(+99.9%) | -$10.50 M(+33.3%) |
| Mar 2018 | - | -$2.32 M(-288.2%) | -$7.87 M(-19.8%) |
| Dec 2017 | -$8.79 M(+55.6%) | $1.23 M(-125.9%) | -$9.82 M(-23.1%) |
| Sep 2017 | - | -$4.77 M(+136.0%) | -$12.76 M(+28.6%) |
| Jun 2017 | - | -$2.02 M(-52.7%) | -$9.92 M(+7.7%) |
| Mar 2017 | - | -$4.27 M(+149.8%) | -$9.22 M(+63.3%) |
| Dec 2016 | -$5.65 M(+217.9%) | -$1.71 M(-11.3%) | -$5.65 M(+21.0%) |
| Sep 2016 | - | -$1.93 M(+46.7%) | -$4.67 M(+42.3%) |
| Jun 2016 | - | -$1.31 M(+88.6%) | -$3.28 M(+41.0%) |
| Mar 2016 | - | -$696.70 K(-4.7%) | -$2.33 M(+31.0%) |
| Dec 2015 | -$1.78 M | -$730.80 K(+35.6%) | -$1.78 M(+69.9%) |
| Sep 2015 | - | -$538.90 K(+49.4%) | -$1.05 M(+106.3%) |
| Jun 2015 | - | -$360.60 K(+146.5%) | -$506.90 K(+246.5%) |
| Mar 2015 | - | -$146.30 K | -$146.30 K |
FAQ
- What is PAVmed annual EBITDA?
- What is the all time high annual EBITDA for PAVmed?
- What is PAVmed annual EBITDA year-on-year change?
- What is PAVmed quarterly EBITDA?
- What is the all time high quarterly EBITDA for PAVmed?
- What is PAVmed quarterly EBITDA year-on-year change?
- What is PAVmed TTM EBITDA?
- What is the all time high TTM EBITDA for PAVmed?
- What is PAVmed TTM EBITDA year-on-year change?
What is PAVmed annual EBITDA?
The current annual EBITDA of PAVM is -$75.74 M
What is the all time high annual EBITDA for PAVmed?
PAVmed all-time high annual EBITDA is -$1.78 M
What is PAVmed annual EBITDA year-on-year change?
Over the past year, PAVM annual EBITDA has changed by +$23.76 M (+23.88%)
What is PAVmed quarterly EBITDA?
The current quarterly EBITDA of PAVM is $60.96 M
What is the all time high quarterly EBITDA for PAVmed?
PAVmed all-time high quarterly EBITDA is $60.96 M
What is PAVmed quarterly EBITDA year-on-year change?
Over the past year, PAVM quarterly EBITDA has changed by +$81.82 M (+392.27%)
What is PAVmed TTM EBITDA?
The current TTM EBITDA of PAVM is $11.79 M
What is the all time high TTM EBITDA for PAVmed?
PAVmed all-time high TTM EBITDA is $11.79 M
What is PAVmed TTM EBITDA year-on-year change?
Over the past year, PAVM TTM EBITDA has changed by +$94.48 M (+114.26%)